Home Biosimilar Antibodies Others Others Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) For research use only.
Not for use in humans.

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

Synonyms: GC33

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

CAS No. 1365267-33-9

Purity & Quality Control

≥99

Biological Activity

Description Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.

Product Details

CAS No. 1365267-33-9
Molecular Weight 145.58
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) supplier | purchase Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) cost | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) manufacturer | order Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) distributor